Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
09/1996
09/19/1996CA2215307A1 Pharmaceutical compositions and kits for preventing erectile dysfunction
09/19/1996CA2214779A1 Use of nitric oxide donor and/or substrate for inducing cervical dilation
09/19/1996CA2214416A1 Novel naphthyl pharmaceutical compounds
09/19/1996CA2214261A1 Novel benzothiophene pharmaceutical compounds
09/18/1996EP0732329A1 Chroman derivative
09/18/1996EP0732101A1 Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals
09/18/1996EP0731790A1 Tachykinin antagonists
09/18/1996EP0731789A1 Dp-iv-serine protease inhibitors
09/18/1996EP0731787A1 Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
09/18/1996EP0731711A1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
09/18/1996CN1131393A Biochemically balanced peritoneal dialysis solutions
09/18/1996CN1131391A Use of thiazolidinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
09/17/1996US5556983 Phenylimidazolidines
09/17/1996US5556981 Angiotensin II antagonist intermediates
09/17/1996US5556753 DNA encoding human α1 adrenegric receptors and uses thereof
09/12/1996WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity
09/12/1996WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
09/12/1996WO1996027375A2 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
09/12/1996WO1996027372A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof
09/12/1996WO1996027292A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
09/12/1996CA2214723A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
09/11/1996EP0731101A1 3-Benzyl-benzothiophenes
09/11/1996EP0731100A1 Benzothiophene pharmaceutical compounds
09/11/1996EP0731099A1 N-(3-benzofuranyl)urea-derivatives
09/11/1996EP0731098A1 Alpha-substituted-3-benzyl-benzofurans
09/11/1996EP0731093A1 Naphthyl pharmaceutical compounds
09/11/1996EP0730657A1 Composition for the in vivo production of therapeutic products
09/11/1996EP0730589A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
09/11/1996EP0730445A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
09/11/1996CN1130866A Anti-angiogenic compositions and method of use
09/11/1996CN1130626A Adhesion receptor antagonists
09/11/1996CA2171404A1 3-benzyl-benzothiophenes
09/11/1996CA2171403A1 .alpha. substituted-1-benzyl-naphthyls
09/11/1996CA2171399A1 Substituted-3-benzyl-benzofurans
09/10/1996US5554642 Arylalkyl(thio) amides
09/10/1996US5554628 Method for minimizing the uterothrophic effect of tamoxifen and tamoxifen analogs
09/10/1996US5554604 Method of controlling male fertility
09/10/1996US5554600 Methods for inhibiting endometriosis
09/10/1996US5554593 Therapeutic agent for threatened abortion
09/07/1996CA2170824A1 N-(3-benzofuranyl)urea-derivatives
09/06/1996WO1996026935A1 2-benzyl-3-arylbenzothiophenes
09/06/1996WO1996026932A1 2-arylbenzazole compounds
09/06/1996WO1996026727A1 Methods of inhibiting ovarian cancer
09/06/1996WO1996016981A3 Peptide compounds for prevention and/or treatment of no-mediated diseases
09/06/1996CA2214134A1 2-benzyl-3-arylbenzothiophenes
09/06/1996CA2214080A1 Methods of inhibiting ovarian cancer
09/04/1996EP0729964A1 Phosphorous-containing benzothiophenes
09/04/1996EP0729956A1 Benzothiophene compounds, intermediates, compositions, and methods
09/04/1996EP0729955A1 2-Benzyl-3-Arylbenzothiophenes useful for the treatment of post-menopausal syndrome
09/04/1996EP0729951A1 Naphthyl compounds, intermediates, compositions, and methods
09/04/1996EP0729758A2 Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders
09/04/1996EP0729755A2 2-Phenyl-3-aroylbenziothiophenen for inhibiting ovarian cancer
09/04/1996EP0729472A1 Piperidinylcamphorsulfonyl oxytocin antagonists
09/04/1996EP0729468A1 Non-peptide tachykinin receptor antagonists
09/04/1996EP0729356A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
09/04/1996CN1130078A Zhuifengtougu plaster for dissipating wind and removing dampness
09/04/1996CN1130063A Estogen effect promoting medicine
09/03/1996US5552417 Preventing premature sexual maturity, benzothiophene derivatives
09/03/1996US5552416 Methods of inhibiting dysfunctional uterine bleeding
09/03/1996US5552404 Compounds for neurotransmitters for animals
09/03/1996US5552403 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
09/03/1996US5552401 2-benzyl-3-arylbenzothiophenes
09/03/1996US5552150 Compostions containing di-linoleoyl-mono-gamma-linolenyl-glycerol
08/1996
08/29/1996WO1996026195A1 Benzothiazine dioxides as endothelin antagonists
08/29/1996WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996CA2213192A1 Alpha.1a. adrenergic receptor antagonists
08/29/1996CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996CA2211027A1 Benzothiazine dioxides as endothelin antagonists
08/29/1996CA2170337A1 Naphthyl compounds, intermediates, compositions, and methods
08/29/1996CA2169414A1 Phosphorous-containing benzothiophenes
08/28/1996EP0728759A1 Heterocyclic compounds
08/28/1996EP0728746A1 Azepinone compounds useful in the inhibition of ACE and NEP
08/28/1996EP0728738A1 Tetralinyl- and indanyl-ethylamides having melatonergic activity
08/28/1996EP0728479A1 Deacetyl moxisylyte in the treatment of acute urinary retention
08/28/1996EP0728209A1 Endothelin-converting enzyme
08/28/1996EP0728147A1 Receptor specific atrial natriuretic peptides
08/28/1996EP0728134A1 6-oxo-nucleosides useful as immunosuppressants
08/28/1996EP0728128A1 Substituted phenyl compounds
08/28/1996EP0728000A1 The use of alfuzosin or terazosin in the treatment of premature ejaculation
08/28/1996EP0727995A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
08/28/1996CN1129907A Inhibition of smooth muscle cell migration by (R)-amlodipine
08/28/1996CN1129702A Imidazopyridines
08/27/1996USRE35321 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity
08/27/1996US5550259 Dicitrate cyclic diester can be used to prevent or reduce the effects of calcification-related disease
08/27/1996US5550212 Analogues of hGH-RH(1-29)NH2 having antagonistic activity
08/27/1996US5550164 Method for inhibiting uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
08/27/1996US5550150 Using a benzothiophene compound
08/27/1996US5550118 Polyhydronorharman synthase inhibitors
08/27/1996US5550110 Pentapeptide and hexapeptide analogs of endothelin-1
08/27/1996US5550107 Anticarcinogenic agents and antiestrogens
08/27/1996US5549674 Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
08/27/1996CA1338555C Agents for treatment of male impotence
08/22/1996WO1996025502A1 Calcineurin regulatable adenylate cyclase
08/22/1996WO1996025440A1 Polymeric compounds
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY
08/22/1996WO1996025168A1 Use of hyaluronic acid for the treatment of interstitial cystitis
08/22/1996CA2210000A1 Polymeric compounds
08/21/1996EP0727425A1 Adhesion receptor antagonists
08/21/1996EP0726779A1 Methods of stimulating phagocytosis
1 ... 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 ... 562